Koren Amir, Sarbagil-Maman Hagit, Litinsky Irina, Furer Victoria, Artzi Ofir
Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Dermatol Surg. 2022 Jan 1;48(1):82-86. doi: 10.1097/DSS.0000000000002888.
Injecting dermal fillers in patients with autoimmune inflammatory rheumatic diseases (AIIRDs) is controversial.
To evaluate the attitudes of patients with AIIRDs regarding the use of dermal fillers and the side effects of those who underwent them.
Patients with AIIRDs who attended a rheumatology outpatient clinic between 2016 and 2018 filled in a questionnaire about their attitudes toward dermal filler injections. The questionnaire evaluated information received from professionals and the factors that influenced their decision of whether or not to undergo the procedures.
Overall, 194 patients with AIIRDs (mean age 56.5 ± 14.0, 99% women) responded. Forty-two of them had previously undergone the injections and intended to repeat them (Group A), 37 had not received filler injections but intended to do so (Group B), and 114 who had never undergone them did not intend to undergo them. The major motivation for undergoing filler injections was social. Patients treated with dermal fillers refrained from informing their rheumatologist about their injections. They were, however, highly satisfied with the procedure and reported negligible side effects.
The use of dermal fillers was apparently safe and well received by patients with AIIRDs. Physicians' recommendations to refrain from injecting them with dermal fillers should be reconsidered and evaluated in clinical studies.
在患有自身免疫性炎性风湿病（AIIRDs）的患者中注射真皮填充剂存在争议。
评估AIIRDs患者对使用真皮填充剂的态度以及接受填充剂治疗患者的副作用情况。
2016年至2018年期间在风湿病门诊就诊的AIIRDs患者填写了一份关于他们对真皮填充剂注射态度的问卷。该问卷评估了从专业人员处获得的信息以及影响他们决定是否接受该治疗的因素。
总体而言，194例AIIRDs患者（平均年龄56.5±14.0岁，99%为女性）做出了回应。其中42人之前接受过注射并打算再次注射（A组），37人未接受过填充剂注射但打算接受（B组），114人从未接受过且不打算接受。接受填充剂注射的主要动机是社交方面。接受真皮填充剂治疗的患者没有告知他们的风湿病医生其注射情况。然而，他们对该治疗非常满意，并且报告副作用可以忽略不计。
对于AIIRDs患者而言，使用真皮填充剂显然是安全的且患者接受度高。医生关于避免为他们注射真皮填充剂的建议应在临床研究中重新考虑和评估。
